A COVID-19 vaccine created through a partnership between Sanofi and GSK showed promising results in a Phase 2 clinical trial. A recombinant protein vaccine, it targets the SARS-CoV-2 spike protein, created via insect cells, with an antibody…

Many scientists believe the origins of the novel coronavirus remain unknown, and that no door should be shut as worldwide investigations continue. A group of scientists penned a letter to the highly regarded journal Science about keeping an…

New research from the United Kingdom finds that when older adults waited 12 weeks before receiving their second dose of the Pfizer COVID-19 vaccine, the resultant level of antibodies produced was 3.5 times higher than among those who…

Colleges and universities are some of the few places that regularly tested their entire populations for COVID-19, providing a rich source for data mining. A new study took advantage of these metrics and found that a small percentage—2%—of…

A hotly debated article based on in vitro evidence suggests that SARS-CoV-2 may insert its own genetic blueprint into the DNA of those who become infected with COVID-19. This would explain why some patients continue to experience positive…

Researchers from The Ohio State University (OSU) School of Dentistry took a close look at the origin of bacteria and viruses in dental aerosols in their article, “Sources of SARS-CoV-2 and Other Microorganisms in Dental Aerosols.” They…

India is facing a daunting COVID-19 crisis with a huge increase in number of cases and deaths amid dwindling resources. Part of India’s pandemic problem may be due to the emergence of a new variant: B.1.617. This variant creates two…

The skies are not as friendly these days with growing numbers of unruly airline passengers who refuse to wear masks, as is currently required on commercial airline flights. The Federal Aviation Administration (FAA) reported 1,300 complaints…

According to United States Census Bureau data, thousands of Americans left large metropolises for smaller areas during the COVID-19 pandemic. The reasons behind these moves were less about fear of the novel coronavirus, and more about a…

Pfizer’s COVID-19 vaccine received Emergency Use Authorization (EAU) from the United States Food and Drug Administration (FDA) in December 2020. Now it is seeking to transition from the EAU to full approval. The two-shot immunization has…